during the swiftly evolving discipline of oncology investigate, precise and effective mutation screening is critical for producing focused therapies. The KRAS solutions System plays a pivotal role In this particular landscape by providing complete methods for KRAS mutation profiling and Assessment. KRAS mutations, present in around 95% of RAS-linke